Kolexia
Pigny Pascal
Pharmacien
Centre de Biologie - Pathologie
Lille, France
136 Activités
193 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome des ovaires polykystiques Diabète de type 1 Phéochromocytome Carcinomes Infertilité féminine Tumeurs de la thyroïde Obésité Paragangliome Diabète

Industries

BECKMAN COULTER FRANCE
1 collaboration(s)
Dernière en 2016
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Update of the UMD-VHL database: classification of 164 challenging variants based on genotype-phenotype correlation among 605 entries.
Journal of medical genetics   18 novembre 2023
Long-COVID cognitive impairments and reproductive hormone deficits in men may stem from GnRH neuronal death.
EBioMedicine   13 septembre 2023
Serum Succinate/Fumarate Ratio in Patients With Paraganglioma/Pheochromocytoma Attending an Endocrine Oncogenetic Unit.
The Journal of clinical endocrinology and metabolism   21 août 2023
Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy.
Human reproduction (Oxford, England)   03 mai 2023
Hypothalamic neuroglial plasticity is regulated by anti-Müllerian hormone and disrupted in polycystic ovary syndrome.
EBioMedicine   29 mars 2023
METAB-OV: Impact of Metabolic Status and Circadian Rhythms on Post-chemotherapy Ovarian Recovery in Women Treated for Breast Cancer
Essai Clinique (CHU Lille)   02 mars 2023
Comparison of biomarker for diagnosis of nitrous oxide abuse: challenge of cobalamin metabolic parameters, a retrospective study.
Journal of neurology   24 janvier 2023
Trial of Deferiprone in Parkinson's Disease.
The New England journal of medicine   09 décembre 2022
FAIRPARKII: Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease. European Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial of Deferiprone"
Essai Clinique (CHU Lille)   04 novembre 2022
Translational research in neuroendocrine tumors (NETs): What's new in 2021?
Annales d'endocrinologie   03 octobre 2022